Literature DB >> 29614310

cxcl12 gene engineered endothelial progenitor cells further improve the functions of oligodendrocyte precursor cells.

Fang Yuan1, Shuang Chang1, Longlong Luo1, Yaning Li1, Liping Wang2, Yaying Song2, Meijie Qu2, Zhijun Zhang1, Guo-Yuan Yang3, Yongting Wang4.   

Abstract

Oligodendrocyte precursor cells (OPCs) are needed for white matter repair after various brain injury. Means that promote OPC functions could benefit white matter recovery after injury. Chemokine CXCL12 and endothelial progenitor cells (EPCs) both have been shown to promote remyelination. We hypothesize that the beneficial effects of EPCs and CXCL12 can be harnessed by genetically modifying EPCs with cxcl12 to synergistically improve the functions of OPCs. In this work, CXCL12-EPC was generated using virus-mediated gene transfer. OPCs were cultured with CXCL12-EPC conditioned media (CM) to analyze its impact on the proliferation, migration, differentiation and survival properties of OPCs. We blocked or knocked-down the receptors of CXCL12, namely CXCR4 and CXCR7, respectively to investigate their functions in regulating OPCs properties. Results revealed that CXCL12-EPC CM further promoted OPCs behavioral properties and upregulated the expression of PDGFR-α, bFGF, CXCR4 and CXCR7 in OPCs, albeit following different time course. Blocking CXCR4 diminished the beneficial effects of CXCL12 on OPCs proliferation and migration, while knocking down CXCR7 inhibited OPCs differentiation. Our results supported that cxcl12 gene modification of EPCs further promoted EPCs' ability in augmenting the remyelination properties of OPCs, suggesting that CXCL12-EPC hold great potential in white matter repair.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CXCL12; CXCR4; CXCR7; Endothelial progenitor cells; Oligodendrocyte precursor cells; White matter

Mesh:

Substances:

Year:  2018        PMID: 29614310     DOI: 10.1016/j.yexcr.2018.03.040

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

1.  Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/β-catenin pathway in a mouse model of middle cerebral artery occlusion.

Authors:  Li-Ping Wang; Jiaji Pan; Yongfang Li; Jieli Geng; Chang Liu; Lin-Yuan Zhang; Panting Zhou; Yao-Hui Tang; Yongting Wang; Zhijun Zhang; Guo-Yuan Yang
Journal:  J Cereb Blood Flow Metab       Date:  2021-12-08       Impact factor: 6.960

2.  M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice.

Authors:  Yongfang Li; Ze Liu; Yaying Song; Jia-Ji Pan; Yixu Jiang; Xiaojing Shi; Chang Liu; Yuanyuan Ma; Longlong Luo; Muyassar Mamtilahun; Zhiyu Shi; Haroon Khan; Qing Xie; Yongting Wang; Yaohui Tang; Zhijun Zhang; Guo-Yuan Yang
Journal:  Theranostics       Date:  2022-04-24       Impact factor: 11.600

3.  Diabetes Mellitus-Related Neurobehavioral Deficits in Mice Are Associated With Oligodendrocyte Precursor Cell Dysfunction.

Authors:  Li-Ping Wang; Jieli Geng; Chang Liu; Yuyang Wang; Zhijun Zhang; Guo-Yuan Yang
Journal:  Front Aging Neurosci       Date:  2022-05-25       Impact factor: 5.702

4.  Conditioned medium-preconditioned EPCs enhanced the ability in oligovascular repair in cerebral ischemia neonatal rats.

Authors:  Ning Zhou; Lei Wang; Ping Fu; Zihao Cui; Yuhang Ge; Feiyu Jiang; Jing Liu; Chao Ren; Zuo Luan; Hongbin Fan; Ruiqin Yao
Journal:  Stem Cell Res Ther       Date:  2021-02-12       Impact factor: 6.832

Review 5.  The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker.

Authors:  Yudie Yan; Jingtong Su; Zhen Zhang
Journal:  Cell Mol Neurobiol       Date:  2021-06-12       Impact factor: 4.231

Review 6.  White-matter repair: Interaction between oligodendrocytes and the neurovascular unit.

Authors:  Gen Hamanaka; Ryo Ohtomo; Hajime Takase; Josephine Lok; Ken Arai
Journal:  Brain Circ       Date:  2018-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.